RISALITI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 21.872
AS - Asia 9.329
EU - Europa 8.144
SA - Sud America 2.002
Continente sconosciuto - Info sul continente non disponibili 432
AF - Africa 244
OC - Oceania 12
Totale 42.035
Nazione #
US - Stati Uniti d'America 21.588
SG - Singapore 4.463
CN - Cina 1.931
UA - Ucraina 1.918
IT - Italia 1.680
BR - Brasile 1.575
DE - Germania 1.492
HK - Hong Kong 886
FR - Francia 787
FI - Finlandia 756
VN - Vietnam 726
RU - Federazione Russa 495
IE - Irlanda 323
IN - India 243
TR - Turchia 197
GB - Regno Unito 195
SE - Svezia 194
AR - Argentina 161
BD - Bangladesh 153
CA - Canada 148
KR - Corea 136
IQ - Iraq 89
ID - Indonesia 86
EC - Ecuador 63
MX - Messico 60
ZA - Sudafrica 60
IR - Iran 55
CO - Colombia 53
VE - Venezuela 49
PK - Pakistan 46
ES - Italia 43
PL - Polonia 43
JP - Giappone 40
MA - Marocco 36
NL - Olanda 35
PH - Filippine 35
SA - Arabia Saudita 35
UZ - Uzbekistan 34
PY - Paraguay 32
AT - Austria 29
EU - Europa 29
BE - Belgio 27
CL - Cile 26
KE - Kenya 26
EG - Egitto 25
CZ - Repubblica Ceca 24
MY - Malesia 24
TN - Tunisia 22
AE - Emirati Arabi Uniti 21
PE - Perù 17
NP - Nepal 16
CR - Costa Rica 15
JO - Giordania 15
KZ - Kazakistan 15
DZ - Algeria 14
UY - Uruguay 13
RO - Romania 12
AL - Albania 11
BG - Bulgaria 10
BO - Bolivia 10
DO - Repubblica Dominicana 10
LB - Libano 10
SN - Senegal 10
LT - Lituania 9
PA - Panama 9
TT - Trinidad e Tobago 9
AU - Australia 8
CH - Svizzera 8
ET - Etiopia 8
TW - Taiwan 8
AO - Angola 7
AZ - Azerbaigian 7
HN - Honduras 7
JM - Giamaica 7
OM - Oman 7
DK - Danimarca 6
EE - Estonia 6
KW - Kuwait 6
TG - Togo 6
XK - ???statistics.table.value.countryCode.XK??? 6
BH - Bahrain 5
GR - Grecia 5
GT - Guatemala 5
LA - Repubblica Popolare Democratica del Laos 5
AM - Armenia 4
CI - Costa d'Avorio 4
GE - Georgia 4
HR - Croazia 4
IL - Israele 4
KG - Kirghizistan 4
NG - Nigeria 4
NO - Norvegia 4
PT - Portogallo 4
TH - Thailandia 4
ZW - Zimbabwe 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BS - Bahamas 3
BY - Bielorussia 3
CY - Cipro 3
Totale 41.575
Città #
Fairfield 2.213
Ashburn 1.585
Singapore 1.574
Woodbridge 1.541
Jacksonville 1.401
Houston 1.115
Chandler 1.025
Wilmington 984
Ann Arbor 925
Dearborn 907
Beijing 900
San Jose 884
Hong Kong 879
Seattle 829
Cambridge 796
Council Bluffs 590
Boardman 420
Los Angeles 357
Princeton 353
Udine 346
Dublin 321
Lauterbourg 309
Ho Chi Minh City 244
Dallas 224
Chicago 183
Munich 175
Hefei 172
Hanoi 161
Buffalo 156
Helsinki 152
São Paulo 135
Izmir 131
Seoul 127
San Diego 120
New York 113
The Dalles 101
Redondo Beach 86
Salt Lake City 80
Mumbai 74
Milan 73
Santa Clara 69
Ogden 66
Norwalk 62
Rio de Janeiro 60
Rome 60
Ottawa 52
Des Moines 49
Frankfurt am Main 49
Dong Ket 48
Nanjing 48
Phoenix 48
Orem 47
Kunming 46
Elk Grove Village 45
Augusta 41
Tampa 38
Brooklyn 36
Baghdad 34
Washington 34
Monmouth Junction 32
Tokyo 32
Shanghai 31
Turku 31
Warsaw 31
Tashkent 30
Toronto 30
Curitiba 29
Leawood 29
Denver 28
Johannesburg 28
London 28
Atlanta 27
Bologna 27
Porto Alegre 27
Düsseldorf 26
Guangzhou 26
Haiphong 26
Belo Horizonte 25
Brussels 25
Chennai 25
Da Nang 24
Nanchang 23
Nuremberg 23
Quito 23
Stockholm 23
Brasília 22
Dhaka 22
Jinan 22
Sterling 22
Nairobi 21
Redmond 21
San Mateo 21
Hải Dương 20
Montreal 20
Pittsburgh 20
Ardabil 19
Florence 19
Pune 19
San Francisco 19
Santo André 19
Totale 24.708
Nome #
Breast Cancer Oncological Outcomes at an Italian Center Following Nipple-Sparing and Skin-Sparing Mastectomy Techniques 464
L’ANASTOMOSI DI SALVATAGGIO CAVO-CAVALE INFRAEPATICA NEL TRAPIANO DI FEGATO CON TECNICA PIGGY-BACK 415
L’ANASTOMOSI DI SALVATAGGIO CAVO-CAVALE INFRAEPATICA NEL TRAPIANTO DI FEGATO CON TECNICA PIGGY-BACK 389
Incidence and Risk Factors for Venous Thromboembolism in Female Patients Undergoing Breast Surgery 355
A Particular Use of Endobag®: Extraction of Rectal Foreign Bodies 326
Extended Ureteral Stricture Corrected with Appendiceal Replacement in a Kidney Transplant Recipient 291
Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: Retrospective observational study 255
LA DERIVAZIONE SPLENO-RENALE SCONDO WARREN NELLA CIRROSI ALCOLICA: VALIDITA' DI ALCUNI ACCORGIMENTI TECNICI 253
In vitro functional assessment of a porcine hepatocytes based bioartificial liver 251
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 243
A single-center experience of late retransplantation of the liver. 239
Steatosis of the graft is a risk factor for posttransplantation biliary complications. 231
Abdominal cross-sectional imaging of the associating liver partition and portal vein ligation for staged hepatectomy procedure 224
GLI ACE-INIBITORI CORREGGONO LA ERITROCITOSI POST-TRAPIANTO RENALE MEDIANTE MECCANISMI ERITROPOIETINO-INDIPENDENTI 218
Ileocecal Fistula Caused by Multiple Foreign Magnetic Bodies Ingestion 215
Detection of transplant renal artery stenosis with contrast-enhanced ultrasound 212
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 208
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 206
Microscopic peritoneal carcinomatosis in gastric cancer: Prevalence, prognosis and predictive factors 203
Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer. 203
Long term results of hepatic resection or orthotopic liver transplantation in patients with liver metastases from gastrointestinal neuroendocrine tumors 202
Development of Small Bowel Volvulus on Barbed V-Loc™ Suture: A Rare Complication after Laparoscopic Ventral Rectopexy 202
Evolution of incidental branch-duct intraductal papillary mucinous neoplasms of the pancreas: A study with magnetic resonance imaging cholangiopancreatography 197
Liver transplantation from old donors into HCV and non-HCV recipients 196
Liver transplantation in neurological Wilson's disease: Is there indication? a case report 195
THE ROLE OF CYP3A5 GENOTYPE AND TACROLIMUS MONITORING IN STABLE KIDNEY TRANSPLANTATIONS 195
Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation 194
CANCRO DEL COLON-RETTO. CONFRONTO FRA STAGING, GRADING E POSITIVITA' DI ALCUNI TUMOR MARKERS 193
Laparoscopic treatment of symptomatic lymphoceles after kidney transplantation 189
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: A large retrospective cross-sectional study 188
TERAPIA A LUNGO TERMINE DELLA ERITROCITOSI POST-TRAPIANTO RENALE CON ACE-INIBITORI: EFFICACIA, SICUREZZA, E MECANISMI D’AZIONE 187
Cryopreserved human hepatocytes from cell bank: In vitro function and clinical application 186
Isolation of Human Hepatocytes from Livers Rejected for Liver Transplantation on a National Basis: Results of a 2 Year-Experience 184
Single-time kidney transplantation and monolateral nephrectomy for hypertension and antihypertensive therapy in renal transplant recipients 184
Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient 181
DE NOVO TUMORS ARE A MAJOR CAUSE OF LATE MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION 179
Complete Remission of Unresectable Hepatocellular Carcinoma after Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization 179
Different miRNA expression in transplanted livers of HCV mono-infected and HCV/HIV co-infected recipients 178
Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection 177
Arterial rupture as the result of fungal arteritis after renal transplantation 176
Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation 176
COMBINED APPROACH FOR SPONTANEOUS RUPTURE OF HEPATOCELLULAR CARCINOMA 174
Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation. 174
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 173
Curative versus palliative surgical resection of liver metastases in patients with neuroendocrine tumors: a meta-analysis of observational studies 172
Acute pancreatitis after kidney transplantation. 172
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS 171
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 171
Quality-of-life assessment before and after liver transplantation. 170
RENAL ALLOGRAFT PROTECTION WITH EARLY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ADMINISTRATION 170
Macrocystic serous cystadenoma of the pancreas: Report of 4 cases 169
Hepatocyte isolation using human livers discarded from transplantation: Analysis of cell yield and function 168
Steatotic versus cirrhotic livers as a source for human hepatocyte isolation 168
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites after Liver Transplantation: Management with Proximal Splenic Artery Embolization 168
Adult-to-adult living donor liver transplantation using left lobes: the importance of surgical modulations on portal graft inflow. 167
Type of breast cancer diagnosis, screening, and survival 166
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients 166
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 165
Surgical and oncological outcomes of free dermal fat graft for breast reconstruction after breast-conserving surgery 165
Resected biliary tract cancers: A novel clinical-pathological score correlates with global outcome 163
Donor safety in living donor liver donation: An Italian multicenter survey 163
Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. 162
Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center 162
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience 162
Graft vessel wall pathology in a case of hepatic artery pseudo-aneurysm in a liver transplant recipient 161
Postsplenectomy recurrence of idiopathic thrombocitopenic purpura: role of laparoscopic splenectomy in the treatment of accessory spleen 161
Future of minimally invasive surgery 160
Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis 159
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. 159
DE NOVO GASTROINTESTINAL TUMOURS AFTER RENAL TRANSPLANTATION: ROLE OF CMV AND EBV VIRUSES 157
MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients 157
Appendicectomy and Crohn's disease: clinical and genetic associations 156
Multimodal treatment of hepatocellular carcinoma on cirrhosis: An update 155
Breast reconstruction with acellular dermal matrix: a brief analysis of costs 154
A national mandatory-split liver policy: A report from the Italian experience 154
De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. 153
Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis 153
Sequential versus contemporaneous portal and arterial reperfusion during liver transplantation. 153
De Novo Solid Tumors after Kidney Transplantation: Is It Time for a Patient-Tailored Risk Assessment? Experience from a Single Center 152
Transarterial chemoembolization does not harm the hepatic artery at transplantation 152
Hepatic portal venous gas in a patient with enterovascular fistula. 151
BENEFIT OF LAPAROSCOPY FOR RECTAL RESECTION IN PATIENTS OPERATED SIMULTANEOUSLY FOR SYNCHRONOUS LIVER METASTASES: PRELIMINARY EXPERIENCE. 151
Spontaneous portal vein arterialization in hepatic artery thrombosis 150
ELDERLY VERSUS YOUNG LIVER TRANSPLANT RECIPIENTS: PATIENT AND GRAFT SURVIVAL. 150
Right lobe living related graft loss due to intrahepatic multiple arterio-portal fistulas. 150
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 150
RENAL TRANSPLANTATION IN A PATIENT AFFECTED BY MOUNIER-KUHN SYNDROME 149
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation 148
HIV-INFECTED PATIENTS AND LIVER TRANSPLANTATION: WHO, WHEN AND WHY 146
Liver Retransplantation in Adults: The Largest Multicenter Italian Study 146
Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation 145
UN NUOVO APPROCCIO NEL TRATTAMENTO LAPAROSCOPICO DEL LINFOCELE DOPO IL TRAPIANTO DI RENE 144
Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report 144
GRAFT VESSEL WALL PATHOLOGY IN A CASE OF HEPATIC ARTERY PSEUDO-ANEURYSM IN A LIVER TRANSPLANT RECIPIENT. 144
Impact of the presence and quantity of ductal carcinoma in situ component on the outcome of invasive breast cancer 144
Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection 142
TREATMENT OF RECURRENT SYMPTOMATIC LYMPHOCELE AFTER KIDNEY TRANSPLANTATION WITH INTRAPERITONEAL TENCKHOFF CATHETER 141
Donor spleen cell isolation for augmentation of donor-cell chimerism in organ transplantation 140
Cardiovascular and metabolic complications after liver transplantation: Neoral- versus tacrolimus-based immunosuppression 140
Gastrointestinal Perforations in Adult Whole-Liver Transplant Patients: Clinical, Radiologic, and Histopathologic Analysis 140
Totale 18.611
Categoria #
all - tutte 155.584
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.584


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.088 0 0 62 102 29 88 117 124 27 491 614 434
2022/20232.530 397 172 44 301 208 690 21 178 332 47 76 64
2023/2024786 106 67 27 20 142 117 13 55 133 47 8 51
2024/20256.066 189 414 193 165 214 322 315 315 598 490 1.008 1.843
2025/202611.069 729 1.710 1.079 1.215 1.520 812 1.054 342 802 914 555 337
2026/20271.162 200 635 327 0 0 0 0 0 0 0 0 0
Totale 42.035